AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9017568 — intervention group
Group type: EXPERIMENTAL
Intervention: Detoxification
Number of subjects: 500
Study 1984613 — intervention group
Group type: EXPERIMENTAL
Intervention: Bismuth subsalicylate (BSS)
Number of subjects: 123
Study 1984613 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study 6685516 — intervention group
Group type: EXPERIMENTAL
Intervention: Piretanide 12 mg
Number of subjects: 12
Study 6685516 — intervention group
Group type: COMPARATOR
Intervention: Furosemide 80 mg
Number of subjects: 12
Study 31172819 — intervention group
Group type: EXPERIMENTAL
Intervention: FriWalk robotic walker
Number of subjects: 42
Study 31623597 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based mental health prevention program
Number of subjects: 1166
Study 31623597 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1166
Study 28363894 — intervention group
Group type: EXPERIMENTAL
Intervention: Short stem femoral component
Number of subjects: 86
Study 28363894 — intervention group
Group type: COMPARATOR
Intervention: Conventional stem femoral component
Number of subjects: 86
Study 28363894 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 86
Study 25222799 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment (Coping Cat) for 12 weeks
Number of subjects: 488
Study 25222799 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication (sertraline) for 12 weeks
Number of subjects: 488
Study 25222799 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of cognitive-behavioral treatment and medication for 12 weeks
Number of subjects: 488
Study 25222799 — intervention group
Group type: COMPARATOR
Intervention: Pill placebo for 12 weeks
Number of subjects: 488
Study 23916715 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT)
Number of subjects: 0
Study 23916715 — intervention group
Group type: COMPARATOR
Intervention: Wait list condition
Number of subjects: 0
Study 21105964 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrap with polyethylene plastic sheets
Number of subjects: 110
Study 21105964 — intervention group
Group type: COMPARATOR
Intervention: Control (dried with warmed towels under a warmer)
Number of subjects: 110
Study 21105964 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrap with polyethylene plastic sheets (among infants <28 weeks' gestation)
Number of subjects: 110
Study 19052049 — intervention group
Group type: EXPERIMENTAL
Intervention: Detailed risk information
Number of subjects: 122
Study 19052049 — intervention group
Group type: COMPARATOR
Intervention: Simple risk information
Number of subjects: 122
Study 16501038 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (850 mg, twice daily)
Number of subjects: 101
Study 16501038 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 16529161 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal replacement therapy (haemodialysis) with polysulphone membranes
Number of subjects: 67
Study 16529161 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal transplantation
Number of subjects: 67
Study 16529161 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher BMI values
Number of subjects: 67
Study 16529161 — intervention group
Group type: EXPERIMENTAL
Intervention: Efficiency of dialysotherapy and ultrafiltration
Number of subjects: 67
Study 16529161 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-transplantation pentosidine concentration
Number of subjects: 67
Study 11387733 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician-Administered PTSD Scale (CAPS)
Number of subjects: 200
Study 1315650 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II (10 ng min‐1 kg‐1)
Number of subjects: 8
Study 1315650 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin II (3 ng min‐1 kg‐1)
Number of subjects: 8
Study 1315650 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5% D-glucose)
Number of subjects: 8
Study 3914313 — intervention group
Group type: EXPERIMENTAL
Intervention: diastolic blood pressure biofeedback
Number of subjects: 52
Study 3914313 — intervention group
Group type: EXPERIMENTAL
Intervention: progressive deep muscle relaxation training
Number of subjects: 52
Study 3914313 — intervention group
Group type: EXPERIMENTAL
Intervention: self‐directed relaxation training
Number of subjects: 52
Study 3914313 — intervention group
Group type: COMPARATOR
Intervention: medication alone
Number of subjects: 52
Study 31960341 — intervention group
Group type: EXPERIMENTAL
Intervention: Social networks influence on weight gain and weight loss; specific intervention details not available.
Number of subjects: 0
Study 31960341 — intervention group
Group type: EXPERIMENTAL
Intervention: Stochastic actor‐oriented modeling; specific intervention details not available.
Number of subjects: 0
Study 31960341 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural experiment or randomized designs; specific intervention details not available.
Number of subjects: 0
Study 30009223 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg ketamine
Number of subjects: 92
Study 30009223 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mg/kg ketamine
Number of subjects: 92
Study 30009223 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg ketamine
Number of subjects: 92
Study 30009223 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 92
Study 26787177 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic cystectomy
Number of subjects: 10
Study 26787177 — intervention group
Group type: COMPARATOR
Intervention: Open cystectomy
Number of subjects: 10
Study 24508795 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-linking once (Group A)
Number of subjects: 30
Study 24508795 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-linking twice (Group B)
Number of subjects: 30
Study 24508795 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-linking three times (Group C)
Number of subjects: 30
Study 24508795 — intervention group
Group type: COMPARATOR
Intervention: All treated groups (A, B, C)
Number of subjects: 30
Study 22560677 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobacco dependence measures
Number of subjects: 60
Study 22560677 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivation to quit smoking measures
Number of subjects: 60
Study 22560677 — intervention group
Group type: EXPERIMENTAL
Intervention: Intention to quit smoking
Number of subjects: 60
Study 22560677 — intervention group
Group type: EXPERIMENTAL
Intervention: Social environmental factors
Number of subjects: 60
Study 20512500 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprint exercise (two 30‐s maximal efforts on a cycle ergometer)
Number of subjects: 7
Study 20512500 — intervention group
Group type: EXPERIMENTAL
Intervention: Boxing (two 30‐s maximal punching efforts)
Number of subjects: 7
Study 20512500 — intervention group
Group type: EXPERIMENTAL
Intervention: Violent video game (10 min of player vs. player combat)
Number of subjects: 7
Study 20512500 — intervention group
Group type: COMPARATOR
Intervention: Inactive days (control)
Number of subjects: 7
Study 20512500 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprint exercise
Number of subjects: 7
Study 18207016 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified-release prednisone tablet taken at bedtime, released with a delay of 4 hours after ingestion.
Number of subjects: 288
Study 18207016 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release prednisone tablet taken in the morning as an active comparator.
Number of subjects: 288
Study 18207016 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified-release prednisone
Number of subjects: 288
Study 18207016 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release prednisone
Number of subjects: 288
Study 15688278 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant HIV-1 envelope glycoprotein subunit (rgp120) vaccine
Number of subjects: 5403
Study 15688278 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5403
Study 12730120 — intervention group
Group type: EXPERIMENTAL
Intervention: Single or double autologous peripheral blood stem cell transplantation
Number of subjects: 74
Study 10774461 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-TNF reagents (infliximab and etanercept)
Number of subjects: 0
Study 10774461 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with methotrexate (MTX)
Number of subjects: 0
Study 10774461 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-1 receptor antagonist
Number of subjects: 0
Study 10774461 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-TNF therapy
Number of subjects: 0
Study 8853471 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric training
Number of subjects: 41
Study 8853471 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight training
Number of subjects: 41
Study 8853471 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study 2059880 — intervention group
Group type: EXPERIMENTAL
Intervention: Deflazacort (DFZ)
Number of subjects: 65
Study 2059880 — intervention group
Group type: COMPARATOR
Intervention: Prednisone (PDN)
Number of subjects: 65
Study 3993898 — intervention group
Group type: EXPERIMENTAL
Intervention: Vented patients (4.5 mm lateral drill hole 4 cm distal the tip of the prosthesis)
Number of subjects: 26
Study 3993898 — intervention group
Group type: COMPARATOR
Intervention: Control group (no venting)
Number of subjects: 26
Study 29026977 — intervention group
Group type: EXPERIMENTAL
Intervention: PVP (PROCEED® Ventral Patch)
Number of subjects: 352
Study 29026977 — intervention group
Group type: COMPARATOR
Intervention: Mesh
Number of subjects: 352
Study 26358166 — intervention group
Group type: EXPERIMENTAL
Intervention: Nut-enriched bread with 30g finely sliced hazelnuts
Number of subjects: 32
Study 26358166 — intervention group
Group type: EXPERIMENTAL
Intervention: Nut-enriched bread with 30g semi-defatted hazelnut flour
Number of subjects: 32
Study 26358166 — intervention group
Group type: EXPERIMENTAL
Intervention: Nut-enriched bread with 15g finely sliced hazelnuts and 15g semi-defatted hazelnut flour
Number of subjects: 32
Study 26358166 — intervention group
Group type: COMPARATOR
Intervention: Control nut-free bread
Number of subjects: 32
Study 25192498 — intervention group
Group type: EXPERIMENTAL
Intervention: Dersalazine sodium 1200 mg/12 h
Number of subjects: 34
Study 25192498 — intervention group
Group type: COMPARATOR
Intervention: Mesalazine 1200 mg/12 h
Number of subjects: 34
Study 25192498 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 25192498 — intervention group
Group type: EXPERIMENTAL
Intervention: Dersalazine sodium
Number of subjects: 34
Study 25192498 — intervention group
Group type: COMPARATOR
Intervention: Mesalazine
Number of subjects: 34
Study 21793108 — intervention group
Group type: EXPERIMENTAL
Intervention: MFT + CBT-E (n=52)
Number of subjects: 95
Study 21793108 — intervention group
Group type: COMPARATOR
Intervention: CBT-E (n=43)
Number of subjects: 95
Study 21524314 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderately high protein diet (30% protein, 40% carbohydrate)
Number of subjects: 83
Study 21524314 — intervention group
Group type: COMPARATOR
Intervention: High fiber, relatively high carbohydrate diet (50% carbohydrate, > 35 g total dietary fiber, 20% protein)
Number of subjects: 83
Study 18377694 — intervention group
Group type: COMPARATOR
Intervention: No additional exercise (Nex)
Number of subjects: 12
Study 18377694 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise (Mex; 1.5-2.0 MJ/d)
Number of subjects: 12
Study 18377694 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise (Hex; 3.0-4.0 MJ/d)
Number of subjects: 12
Study 17062305 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release glipizide (GSR) 10 mg PO QD
Number of subjects: 57
Study 17062305 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release glipizide (GIR) 5 mg PO BID
Number of subjects: 57
Study 17062305 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release glipizide (GSR)
Number of subjects: 57
Study 17062305 — intervention group
Group type: COMPARATOR
Intervention: Immediate-release glipizide (GIR)
Number of subjects: 57
Study 12933344 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week exercise training
Number of subjects: 75
Study 10880063 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilot psychological intervention program for stress management techniques
Number of subjects: 22
Study 10880063 — intervention group
Group type: COMPARATOR
Intervention: Standard care preparation for child's BMT
Number of subjects: 22
Study 8918625 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron saccharate (10-100 mg)
Number of subjects: 18
Study 8918625 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron saccharate (100 mg)
Number of subjects: 18
Study 8918625 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous iron saccharate (10-40 mg)
Number of subjects: 18
Study 1417433 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy (alone or in combination with medication)
Number of subjects: 0
Study 1417433 — intervention group
Group type: COMPARATOR
Intervention: Imipramine hydrochloride pharmacotherapy
Number of subjects: 0
Study 1417433 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined cognitive-pharmacotherapy
Number of subjects: 0
Study 6399888 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiloride 5 mg
Number of subjects: 12
Study 6399888 — intervention group
Group type: EXPERIMENTAL
Intervention: Frusemide 40 mg
Number of subjects: 12
Study 6399888 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination tablet (40 mg frusemide and 5 mg amiloride)
Number of subjects: 12
Study 6399888 — intervention group
Group type: COMPARATOR
Intervention: Control (no diuretics)
Number of subjects: 12
Study 30613127 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally tailored online human subjects curriculum
Number of subjects: 244
Study 30613127 — intervention group
Group type: COMPARATOR
Intervention: Standard nationally used online curriculum
Number of subjects: 244
Study 30613127 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 244
Study 30613127 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally tailored curriculum
Number of subjects: 244
Study 30613127 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally tailored research ethics curriculum
Number of subjects: 244
Study 30982021 — intervention group
Group type: EXPERIMENTAL
Intervention: Jacobson progressive muscular relaxation (PMR)
Number of subjects: 58
Study 30982021 — intervention group
Group type: COMPARATOR
Intervention: Relaxing music (control)
Number of subjects: 58
Study 26686053 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermafil (TF)
Number of subjects: 112
Study 26686053 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Lateral Condensation (CLC)
Number of subjects: 112
Study 24380874 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural voice therapy
Number of subjects: 200
Study 24380874 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate treatment
Number of subjects: 200
Study 24380874 — intervention group
Group type: COMPARATOR
Intervention: Delayed treatment (after eight week assessment)
Number of subjects: 200
Study 22581647 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid
Number of subjects: 66
Study 22581647 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 22581647 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls without osteopenia/osteoporosis
Number of subjects: 66
Study 22581647 — intervention group
Group type: COMPARATOR
Intervention: Postmenopausal women with osteoporosis
Number of subjects: 66
Study 20384746 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen tablets postoperatively according to a standard protocol
Number of subjects: 300
Study 20384746 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 17021589 — intervention group
Group type: EXPERIMENTAL
Intervention: SmartStep auditory biofeedback
Number of subjects: 0
Study 17021589 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 0
Study 16061590 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast (5 mg, once daily)
Number of subjects: 994
Study 16061590 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone (100 microg, twice daily)
Number of subjects: 994
Study 16061590 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 994
Study 16061590 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone
Number of subjects: 994
Study 12153622 — intervention group
Group type: EXPERIMENTAL
Intervention: Metallic stent
Number of subjects: 50
Study 12153622 — intervention group
Group type: COMPARATOR
Intervention: Plastic endoprosthesis
Number of subjects: 50
Study 10196011 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevelamer hydrochloride
Number of subjects: 84
Study 10196011 — intervention group
Group type: COMPARATOR
Intervention: Calcium acetate
Number of subjects: 84
Study 7768240 — intervention group
Group type: EXPERIMENTAL
Intervention: Gas mixture with reduced oxygen content (H; oxygen fraction in inspired gas 0.14)
Number of subjects: 14
Study 7768240 — intervention group
Group type: COMPARATOR
Intervention: Air (N)
Number of subjects: 14
Study 7768240 — intervention group
Group type: EXPERIMENTAL
Intervention: Gas mixture with reduced oxygen content (H)
Number of subjects: 14
Study 2180658 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofu-based frozen dessert (TFD) containing high-fructose corn syrups
Number of subjects: 12
Study 2180658 — intervention group
Group type: COMPARATOR
Intervention: Dairy-based sucrose-sweetened ice cream (IC)
Number of subjects: 12
Study 7418951 — intervention group
Group type: EXPERIMENTAL
Intervention: Biperiden hydrochloride (Akineton)
Number of subjects: 0
Study 7418951 — intervention group
Group type: COMPARATOR
Intervention: Benzhexol (Artane)
Number of subjects: 0
Study 30813605 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutri-Score information provided
Number of subjects: 0
Study 30813605 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Nutri-Score information)
Number of subjects: 0
Study 28609532 — intervention group
Group type: EXPERIMENTAL
Intervention: FAST examination
Number of subjects: 975
Study 28609532 — intervention group
Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 975
Study 25863549 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message reminders
Number of subjects: 3812
Study 25863549 — intervention group
Group type: COMPARATOR
Intervention: Control group (no text message reminders)
Number of subjects: 3812
Study 24090125 — intervention group
Group type: EXPERIMENTAL
Intervention: Diarrhea Pack (ORS, Zinc, water purification, improved hygiene and sanitation)
Number of subjects: 8
Study 24090125 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention specified)
Number of subjects: 8
Study 21854162 — intervention group
Group type: EXPERIMENTAL
Intervention: Bed-rest exercise and music (n = 6)
Number of subjects: 11
Study 21854162 — intervention group
Group type: COMPARATOR
Intervention: Bed-rest and music (n = 5)
Number of subjects: 11
Study 19957871 — intervention group
Group type: EXPERIMENTAL
Intervention: Pool-aquatic program in warm water (three weekly 60-min sessions for four months)
Number of subjects: 14
Study 19957871 — intervention group
Group type: EXPERIMENTAL
Intervention: Pool-aquatic program in warm water
Number of subjects: 14
Study 17067587 — intervention group
Group type: EXPERIMENTAL
Intervention: Forearm vasodilatation in response to endothelium-dependent dilators (acetylcholine/bradykinin)
Number of subjects: 24
Study 17067587 — intervention group
Group type: EXPERIMENTAL
Intervention: Forearm vasodilatation in response to endothelium-independent dilators (nitroprusside/verapamil)
Number of subjects: 24
Study 17067587 — intervention group
Group type: COMPARATOR
Intervention: Vascular function in obese or lean women with PCOS
Number of subjects: 24
Study 17067587 — intervention group
Group type: EXPERIMENTAL
Intervention: Androgen levels
Number of subjects: 24
Study 17067587 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index (BMI)
Number of subjects: 24
Study 12852237 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (drugs such as cyclophosphamide, 5-fluorouracil, and doxorubicin)
Number of subjects: 0
Study 12852237 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 10709795 — intervention group
Group type: EXPERIMENTAL
Intervention: Gimme 5 intervention (curriculum, newsletters, videotapes, point-of-purchase education)
Number of subjects: 16
Study 10709795 — intervention group
Group type: EXPERIMENTAL
Intervention: Gimme 5 intervention
Number of subjects: 16
Study 9327037 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgrastim (r-metHuG-CSF) 75-600 micrograms day-1
Number of subjects: 30
Study 9327037 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgrastim (r-metHuG-CSF) 150-600 micrograms day-1
Number of subjects: 30
Study 9327037 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgrastim (r-metHuG-CSF)
Number of subjects: 30
Study 8138869 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehearsal-plus
Number of subjects: 57
Study 8138869 — intervention group
Group type: EXPERIMENTAL
Intervention: General information
Number of subjects: 57
Study 8138869 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 57
Study 3733311 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise regimen
Number of subjects: 28
Study 3733311 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric exercise regimen
Number of subjects: 28
Study 3733311 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentric exercise regimen
Number of subjects: 28
Study 28941196 — intervention group
Group type: EXPERIMENTAL
Intervention: Vortioxetine (single rising doses)
Number of subjects: 130
Study 28941196 — intervention group
Group type: EXPERIMENTAL
Intervention: Vortioxetine (multiple doses)
Number of subjects: 130
Study 28941196 — intervention group
Group type: EXPERIMENTAL
Intervention: Vortioxetine (fed state)
Number of subjects: 130
Study 28941196 — intervention group
Group type: EXPERIMENTAL
Intervention: Vortioxetine
Number of subjects: 130
Study 28941196 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 27383469 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-paced exercise (not to exceed 76% maximum heart rate)
Number of subjects: 59